Found 4 matching trials
A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying PHASE2 Gastric emptying is the end-result of a complex and carefully regulated ser...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis PHASE2 GSK962040 is a novel small molecule motilin agonist. The Phase I studies (M...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study to Evaluate the Effect of Camicinal on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects With Gastroparesis PHASE2 This study is a randomized, double-blind, placebo controlled trial designed...
Show More Location
GSK Investigational Site
Learn More & Join Trial
The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis PHASE2 The purpose of this study is to assess the pharmacodynamic effects (gastric...
Show More Location
GSK Investigational Site
Learn More & Join Trial